Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

NCT05865886 ·Status: COMPLETED ·Phase: PHASE2

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

NCT05010577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study With Phage for CF Subjects With Pseudomonas Lung Infection

NCT06998043 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

NCT06872892 ·Status: RECRUITING ·Phase: PHASE3

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

NCT01695343 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis

NCT02950805 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

NCT01335464 ·Status: COMPLETED ·Phase: PHASE3

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

NCT06280391 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

NCT03573505 ·Status: TERMINATED ·Phase: PHASE2

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

NCT04093024 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT04419506 ·Status: COMPLETED ·Phase: PHASE2

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis

NCT00769119 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

NCT07023354 ·Status: RECRUITING ·Phase: PHASE1

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT05846230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

NCT02509091 ·Status: UNKNOWN ·Phase: PHASE4

Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

NCT05495243 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT06335303 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT02538536 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II

NCT01335477 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT06360094 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis

NCT05349760 ·Status: WITHDRAWN ·Phase: PHASE2

A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT04968574 ·Status: COMPLETED ·Phase: PHASE2

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

NCT04308681 ·Status: COMPLETED ·Phase: PHASE2

Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis

NCT00547053 ·Status: COMPLETED ·Phase: PHASE1